Who owns Revolution Medicines (RVMD)? Superinvestor holders

5 superinvestors of the 157 tracked here hold Revolution Medicines (RVMD) in their latest 13F filing, with $5.2B between them. Andrew Spokes gives it the most weight: 14.4% of the reported portfolio. In their latest reported quarter, Julian and Felix Baker, Stanley Druckenmiller and Louis Bacon added; Andrew Spokes and Brandon Haley reduced.

Hold it now
5
of 157 tracked
Combined value
$5.2B
Bought / sold
3 / 2
last quarter

Key facts

Superinvestors holding it
5 of 157
Biggest holder
Andrew Spokes, $2.8B
Largest weight
Andrew Spokes, 14.4%of their portfolio
Combined value
$5.2B
Bought last quarter
3
Sold last quarter
2

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding RVMD, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Andrew SpokesFarallon Capital Management14.4%$2.8B13.42M▼ Reduced 1.0%−131.44KQ3 2026
2Julian and Felix BakerBaker Bros. Advisors10.7%$2.1B11.44M▲ Added 20%+1.89MQ2 2026
3Stanley DruckenmillerDuquesne Family Office1.72%$74.8M399.59K▲ Added 27%+83.73KQ2 2026
4Brandon HaleyHolocene Advisors0.58%$254.6M1.36M▼ Reduced 45%−1.11MQ2 2026
5Louis BaconMoore Capital Management0.49%$17.5M85.18K▲ Added 4.3%+3.48KQ3 2026

Quarter by quarter

Superinvestor ownership of RVMD by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 202692213.5M$2.8B11
Q2 2026157526.83M$5B32
Q1 2026157526M$2.5B32
Q4 2025157425.95M$2.1B12
Q3 2025157327.52M$1.3B21
Q2 2025157327.32M$1B21
Q1 2025156325.16M$889.8M20
Q4 2024156324.18M$1.1B30

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of RVMD held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Andrew Spokes13.42M13.55M13.6M14.58M14.63M14.33M13.53M13.25M
Louis Bacon85.18K81.7K55.6K—————
Julian and Felix Baker·11.44M9.56M9.46M9.46M9.36M7.94M7.94M
Brandon Haley·1.36M2.47M1.91M3.44M3.63M3.69M3M
Stanley Druckenmiller·399.59K315.86K—————
Temasek———3.15K————

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own RVMD?

In their latest 13F filings: Andrew Spokes (14.4% of the portfolio, $2.8B), Julian and Felix Baker (10.7% of the portfolio, $2.1B), Stanley Druckenmiller (1.72% of the portfolio, $74.8M), Brandon Haley (0.58% of the portfolio, $254.6M), Louis Bacon (0.49% of the portfolio, $17.5M).

Who bought RVMD last quarter?

Julian and Felix Baker (added 20%), Stanley Druckenmiller (added 27%), Louis Bacon (added 4.3%). “Last quarter” is each investor's latest reported quarter.

Who sold RVMD last quarter?

Reduced: Andrew Spokes (1.0% fewer shares), Brandon Haley (45% fewer shares).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Revolution Medicines (RVMD)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/RVMD/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to RVMD by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.